- Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate. Linz, W., Klaus, E., Albus, U., Becker, R., Mania, D., Englert, H.C., Schölkens, B.A. Arzneimittel-Forschung. (1992)